Acetazolamide and human carbonic anhydrases: retrospect, review and discussion of an intimate relationship
Acetazolamide (AZM) is a strong pharmacological sulphonamide-type (R-SO2-NH2, pKa 7.2) inhibitor of the activity of several carbonic anhydrase (CA) isoforms, notably of renal CA II (Ki, 12 nM) and CA IV (Ki, 74 nM). AZM is clinically used for about eighty years in various diseases including epilepsy...
Saved in:
Main Author: | Dimitrios Tsikas |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2023.2291336 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of carbonic anhydrase and cholinesterase enzymes by acetone extract of Bryoria capillaris (Ach.) Brodo & D.Hawksw.
by: Murat Şentürk, et al.
Published: (2024-02-01) -
Comparing standard treatment of moderate to severe obstructive sleep apnoea to add-on acetazolamide treatment: An open-label randomised controlled trial
by: Anurag Tripathi, et al.
Published: (2025-01-01) -
Arylsulfonamido-alkyl-sulfamates act as inhibitors of bovine carbonic anhydrase II
by: Toni C. Denner, et al.
Published: (2024-12-01) -
Granuloma annulare following acetazolamide challenge/rechallenge in a patient with idiopathic intracranial hypertension
by: Samantha A. Mannala, MS, et al.
Published: (2025-03-01) -
Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide–hydantoin hybrids
by: Morteza Abdoli, et al.
Published: (2024-12-01)